Onderneming Q BioMed Inc. Other OTC
Aandelen
QBIO
US74736N1054
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
USD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Biomedical
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | +45,38% |
Verkoop per regio
USD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | +45,38% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Denis Corin
CEO | Chief Executive Officer | 51 | 21-04-15 |
Ari Jatwes
DFI | Director of Finance/CFO | - | - |
Director/Board Member | 55 | 01-06-15 | |
Keith Pinder
IRC | Investor Relations Contact | - | - |
Robert Derham
PRN | Corporate Officer/Principal | - | - |
Geoff Fatzinger
LAW | General Counsel | - | 31-03-20 |
Corporate Officer/Principal | 69 | 16-12-15 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 55 | 01-06-15 | |
Denis Corin
CEO | Chief Executive Officer | 51 | 21-04-15 |
Rick Panicucci
BRD | Director/Board Member | 63 | 13-02-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 1 000 000 | 0 | 0 | 97,01 % |
Aandeel B | 0 | 296 000 | 0 | 0 | |
Aandeel C | 0 | 500 000 | 0 | 272 002 ( 54,40 %) | |
Aandeel D | 1 | 145 094 531 | 140 760 821 ( 97,01 %) | 0 |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,91% | 118 mld. | |
+11,60% | 106 mld. | |
-4,68% | 24,28 mld. | |
-0,82% | 21,96 mld. | |
-10,12% | 18,16 mld. | |
-42,12% | 16,37 mld. | |
-17,47% | 15,56 mld. | |
+2,77% | 13,63 mld. | |
+34,58% | 12,27 mld. |